United States Active Implantable Medical Devices Market Size, Share & Trends Analysis Report By Product Type (Implantable Cardioverter Defibrillators, Transvenous Implantable Cardioverter Defibrillators, Subcutaneous Implantable Cardioverter Defibrillators, Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, Active Hearing Implants, Non-active/Passive Hearing Implants), By End-User (Hospitals, Ambulatory Surgery Centers, Specialty Clinics, Others) and By Country (U.S., Canada) Forecasts, 2026-2034

United States Active Implantable Medical Devices Market Size

The United States active implantable medical devices market size was valued at USD 8.12 billion in 2025 and is projected to grow from USD 8.84 billion in 2026 to reach USD 17.42 billion by 2034, growing at a CAGR of 8.85% during the forecast period 2026–2034.

The market’s growth is fueled by the increasing prevalence of chronic diseases, advancements in medical device technology, and a robust healthcare infrastructure. Additionally, the market is driven by innovation and growing demand for improved patient care.

United States Active Implantable Medical Devices Market Segmentation Analysis

By Product

Implantable cardioverter defibrillators dominate the product segment and are expected to grow at a CAGR of 7.1% over the forecast period. The rise in cases of arrhythmias and sudden cardiac arrests fuels demand. Subcutaneous ICDs, which reduce complications associated with traditional devices, have gained popularity. Leading manufacturers like Boston Scientific are introducing advanced models tailored to the aging population.

Request Customizationto receive a tailored report.

By End User

Hospitals dominate the end-user segment and are expected to grow at a CAGR of 6.6% during the forecast period. These facilities remain the primary centers for AIMD implantation, driven by their advanced infrastructure and skilled professionals. The rise in hospital networks integrating cutting-edge technologies enhances their dominance in the market.

Speak to an Analystto discuss market opportunities.

United States Active Implantable Medical Devices Market Regional Insights

The market is characterized by robust healthcare infrastructure, technological innovation, and substantial investment in research and development. Growth patterns vary across cities based on healthcare spending, population demographics, and access to advanced medical care.

• New York City, with its world-class medical facilities, is a leading hub for AIMD adoption. Hospitals like Mount Sinai are pioneers in adopting advanced AIMD technologies. The city’s high prevalence of cardiovascular diseases supports steady market growth.
• Los Angeles is witnessing a surge in neurostimulator adoption, driven by its aging population and increasing awareness of chronic pain management. Key players like Abbott Laboratories have partnered with local healthcare providers to expand their reach.
• Houston’s prominence in medical research, particularly at institutions like the Texas Medical Center, has positioned it as a key contributor to the AIMDs market. The city’s emphasis on precision medicine and innovative therapies drives growth.
• Chicago’s healthcare facilities focus on affordable and accessible care, fostering the adoption of AIMDs. Government initiatives and local partnerships with manufacturers like Medtronic have strengthened the region's market.
• Boston’s rich ecosystem of medical device startups and research institutions ensures a steady innovation pipeline. Collaborations between universities and companies drive advancements in AIMD technology, particularly in neuromodulation.

List of Key and Emerging Players in United States Active Implantable Medical Devices Market